Correction of peripheral lysosomal accumulation in mice with aspartylglucosaminuria by bone marrow transplantation
- 1 September 1999
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 27 (9) , 1467-1474
- https://doi.org/10.1016/s0301-472x(99)00075-2
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Adenovirus-mediated gene transfer results in decreased lysosomal storage in brain and total correction in liver of aspartylglucosaminuria (AGU) mouseGene Therapy, 1998
- Bone marrow transplantation prolongs life span and ameliorates neurologic manifestations in Sandhoff disease mice.Journal of Clinical Investigation, 1998
- Primary Folding of AspartylglucosaminidaseJournal of Biological Chemistry, 1996
- Ser72Pro active-site disease mutation in human lysosomal aspartylglucosaminidase: abnormal intracellular processing and evidence for extracellular activationHuman Molecular Genetics, 1996
- Three-dimensional structure of human lysosomal aspartylglucosaminidaseNature Structural & Molecular Biology, 1995
- Correction of Deficient Enzyme Activity in a Lysosomal Storage Disease, Aspartylglucosaminuria, by Enzyme Replacement and Retroviral Gene TransferHuman Gene Therapy, 1995
- Overexpression of human alpha-galactosidase A results in its intracellular aggregation, crystallization in lysosomes, and selective secretion.The Journal of cell biology, 1992
- Amelioration of clinical disease following bone marrow transplantation in fucosidase‐deficient dogsAmerican Journal of Medical Genetics, 1992
- Effect of bone marrow transplantation on enzyme levels and clinical course in the neurologically affected twitcher mouse.Journal of Clinical Investigation, 1988
- Donor-Derived Cells in the Central Nervous System of Twitcher Mice After Bone Marrow TransplantationScience, 1988